Population Health Sciences

You are here

Publications

Found 289 results

Author Title Type [ Year

]

Filters: First Letter Of Last Name is C [Clear All Filters]

2019

Baber JT, Mao J, Sedrakyan A, Connolly PH, Meltzer AJ. 2019. Impact of provider characteristics on use of endovenous ablation procedures in Medicare beneficiaries.. J Vasc Surg Venous Lymphat Disord. 7(2):203-209.e1.

D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al.. 2019. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.

Grossman LV, Creber RMMasterso, Benda NC, Wright D, Vawdrey DK, Ancker JS. 2019. Interventions to increase patient portal use in vulnerable populations: a systematic review.. J Am Med Inform Assoc. 26(8-9):855-870.

Carlo AD, Jeng PJ, Bao Y, Unützer J. 2019. The Learning Curve After Implementation of Collaborative Care in a State Mental Health Integration Program.. Psychiatr Serv. 70(2):139-142.

Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F et al.. 2019. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.. Eur Urol Oncol. 2(2):135-140.

Veinot TC, Ancker JS, Cole-Lewis H, Mynatt ED, Parker AG, Siek KA, Mamykina L. 2019. Leveling Up: On the Potential of Upstream Health Informatics Interventions to Enhance Health Equity.. Med Care. 57 Suppl 6 Suppl 2:S108-S114.

Baik D, Reading M, Jia H, Grossman LV, Creber RMasterson. 2019. Measuring health status and symptom burden using a web-based mHealth application in patients with heart failure.. Eur J Cardiovasc Nurs. 18(4):325-331.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Khullar D, Wolfson D, Casalino LP. 2019. Patient-Centered Performance Metrics-Reply.. JAMA. 321(18):1829-1830.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al.. 2019. Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP. 2019. A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP. 2019. A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.

Lazow SP, Venn RA, Lubor B, Kocharian G, Kreines FM, Gilbert E, Marnell CS, Cricco-Lizza E, Cooley V, Christos P et al.. 2019. The PreOp Program: Intensive Preclinical Surgical Exposure is Associated With Increased Medical Student Surgical Interest and Competency.. J Surg Educ.

Lazow SP, Venn RA, Lubor B, Kocharian G, Kreines FM, Gilbert E, Marnell CS, Cricco-Lizza E, Cooley V, Christos P et al.. 2019. The PreOp Program: Intensive Preclinical Surgical Exposure is Associated With Increased Medical Student Surgical Interest and Competency.. J Surg Educ.

Lazow SP, Venn RA, Lubor B, Kocharian G, Kreines FM, Gilbert E, Marnell CS, Cricco-Lizza E, Cooley V, Christos P et al.. 2019. The PreOp Program: Intensive Preclinical Surgical Exposure is Associated With Increased Medical Student Surgical Interest and Competency.. J Surg Educ.

Awad SF, O'Flaherty M, El-Nahas KG, Al-Hamaq AO, Critchley JA, Abu-Raddad LJ. 2019. Preventing type 2 diabetes mellitus in Qatar by reducing obesity, smoking, and physical inactivity: mathematical modeling analyses.. Popul Health Metr. 17(1):20.

Casalino LP, Saiani R, Bhidya S, Khullar D, O'Donnell E. 2019. Private Equity Acquisition of Physician Practices.. Ann Intern Med. 171(1):78.

Brown B, O'Donnell E, Casalino LP. 2019. Private Equity Investment in Behavioral Health Treatment Centers.. JAMA Psychiatry.

Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hess J, Banta-Green C, Whiteside L, Finegood B et al.. 2019. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. Int J Drug Policy. 67:9-18.

Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS. 2019. Racial Disparities in Virologic Failure and Tolerability During First-Line HIV Antiretroviral Therapy.. Open Forum Infect Dis. 6(2):ofz022.

Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B et al.. 2019. A Randomized Placebo-Controlled Trial of Low- Versus Moderate-Dose Vitamin D3 Supplementation on Bone Mineral Density in Postmenopausal Women With HIV.. J Acquir Immune Defic Syndr. 80(3):342-349.